back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-05-21 13:07 Tx date 2025-02-26 |
$DRUG
Bright Minds Biosciences Inc. |
Cheung, Ryan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$250,950
+5,000 vol $50.19 each |
5,000 | |
| Filed 2025-04-06 08:09 Tx date 2025-04-02 |
$DRUG
Bright Minds Biosciences Inc. |
Pedersen, Jan Torleif
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-120,960
-2,400 vol $50.40 each |
57,600 | |
| Filed 2025-03-28 18:05 Tx date 2025-03-24 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$9,200
+5,000 vol $1.84 each |
5,000 | |
| Filed 2025-03-28 18:02 Tx date 2025-03-24 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-9,200
-5,000 vol $1.84 each |
15,000 | |
| Filed 2025-03-28 17:57 Tx date 2025-03-04 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$100,000
+16,000 vol $6.25 each |
20,609 | |
| Filed 2025-03-28 17:56 Tx date 2025-03-04 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-100,000
-16,000 vol $6.25 each |
30,000 | |
| Filed 2025-03-17 20:03 Tx date 2024-10-30 |
$DRUG
Bright Minds Biosciences Inc. |
Smith, Mark Alan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$123,750
+15,000 vol $8.25 each |
15,000 | |
| Filed 2025-03-17 20:02 Tx date 2022-12-01 |
$DRUG
Bright Minds Biosciences Inc. |
Smith, Mark Alan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-03-17 20:02 Tx date 2024-10-30 |
$DRUG
Bright Minds Biosciences Inc. |
Smith, Mark Alan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-123,750
-15,000 vol $8.25 each |
45,000 | |
| Filed 2025-03-17 20:00 Tx date 2023-07-14 |
$DRUG
Bright Minds Biosciences Inc. |
Smith, Mark Alan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-240,000 vol |
60,000 | |
| Filed 2025-03-06 19:03 Tx date 2025-02-28 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-180,985
-5,000 vol $36.20 each |
0 | |
| Filed 2025-02-03 17:27 Tx date 2025-02-03 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
-188,940 vol |
4,609 | |
| Filed 2025-02-03 17:24 Tx date 2025-01-27 |
$DRUG
Bright Minds Biosciences Inc. |
McDonald, Ian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+30,000 vol |
1,004,900 | |
| Filed 2025-02-03 17:23 Tx date 2025-01-27 |
$DRUG
Bright Minds Biosciences Inc. |
McDonald, Ian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSU)
57 - Exercise of rights
|
-30,000 vol |
30,000 | |
| Filed 2025-02-03 17:21 Tx date 2025-01-27 |
$DRUG
Bright Minds Biosciences Inc. |
Pedersen, Jan Torleif
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+25,000 vol |
60,000 | |
| Filed 2025-02-03 17:20 Tx date 2025-01-27 |
$DRUG
Bright Minds Biosciences Inc. |
Pedersen, Jan Torleif
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSU)
57 - Exercise of rights
|
-25,000 vol |
35,000 | |
| Filed 2024-12-10 14:03 Tx date 2024-12-06 |
$DRUG
Bright Minds Biosciences Inc. |
Pedersen, Jan Torleif
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,411,795
-25,000 vol $56.47 each |
35,000 | |
| Filed 2024-12-10 14:02 Tx date 2024-10-18 |
$DRUG
Bright Minds Biosciences Inc. |
Pedersen, Jan Torleif
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+60,000 vol |
60,000 | |
| Filed 2024-12-09 16:45 Tx date 2024-10-03 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,500
+10,000 vol $1.65 each |
||
| Filed 2024-12-09 16:44 Tx date 2024-03-22 |
$DRUG
Bright Minds Biosciences Inc. |
Bottler, Nils
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$36,800
+20,000 vol $1.84 each |